Detalhe da pesquisa
1.
Unravelling vagal hypersensitivity in chronic cough: A distinct disease.
J Physiol
; 2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642341
2.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lancet
; 399(10328): 909-923, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248186
3.
Modulation of transient receptor potential (TRP) channels by plant derived substances used in over-the-counter cough and cold remedies.
Respir Res
; 24(1): 45, 2023 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755306
4.
The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial.
Respir Res
; 24(1): 109, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041539
5.
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Ann Allergy Asthma Immunol
; 130(1): 60-66, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569802
6.
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.
Lung
; 201(3): 255-266, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261531
7.
ATP, an attractive target for the treatment of refractory chronic cough.
Purinergic Signal
; 18(3): 289-305, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727480
8.
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.
Lung
; 200(4): 423-429, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895098
9.
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?
Lung
; 199(2): 113-119, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569660
10.
Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations.
Lung
; 199(2): 131-137, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829322
11.
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Lung
; 199(2): 121-129, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825965
12.
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
Eur Respir J
; 55(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515408
13.
Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?
Lung
; 198(5): 767-770, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910307
14.
Cough persistence in adults with chronic cough: A 4-year retrospective cohort study.
Allergol Int
; 69(4): 588-593, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327301
15.
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study.
Eur Respir J
; 54(1)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023843
16.
Characterisation of a New Human Alveolar Macrophage-Like Cell Line (Daisy).
Lung
; 197(6): 687-698, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732808
17.
Reply to Weinberger.
Am J Respir Crit Care Med
; 207(12): 1650-1651, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104844
18.
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
Am J Respir Crit Care Med
; 207(11): 1539-1542, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996347
19.
Does FeNO Predict Clinical Characteristics in Chronic Cough?
Lung
; 196(1): 59-64, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29177539
20.
Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
Am J Respir Crit Care Med
; 205(9): 985-986, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202560